Tick Immunity Compositions and Methods
Summary
USPTO published patent application US20260091095A1 by inventors Erol Fikrig and Sukanya Narasimhan for compositions and methods generating tick immunity. The application (No. 19320550) was filed September 5, 2025, and published April 2, 2026. The invention covers pharmaceutical compositions for tick immunity under CPC classifications A61K 39/0003, A61P 33/14, and related subclasses.
What changed
USPTO published patent application US20260091095A1 titled 'Compositions and Methods for Generating Tick Immunity' filed by inventors Erol Fikrig and Sukanya Narasimhan. The application claims compositions and methods for generating immunity against ticks, classified under A61K 39/0003 (medicinal preparations containing antigens), A61P 33/14 (antiparasitic preparations), and A61P 37/04 (immunostimulants). This is a published patent application, not an issued patent, and represents an early-stage intellectual property filing.
This publication is informational for research institutions, pharmaceutical companies, and biotech firms working in parasitology or immunology. Parties conducting similar R&D should review the pending claims to assess potential freedom-to-operate issues. No compliance deadlines or penalties apply to this notice. Patent prosecution typically takes 2-3 years before grant or rejection.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Compositions and Methods for Generating Tick Immunity
Application US20260091095A1 Kind: A1 Apr 02, 2026
Inventors
Erol Fikrig, Sukanya Narasimhan
Abstract
In various aspects and embodiments, the invention provides methods and compositions for generating tick immunity.
CPC Classifications
A61K 39/0003 A61P 33/14 A61P 37/04 A61K 2039/55505 A61K 2039/55566
Filing Date
2025-09-05
Application No.
19320550
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.